688336.SH
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 32.36
+0.94%Next report
Analyst consensus
- Next report date
- Mar 31, 2027
- EPS estimate
- CNY 0.15
- Revenue estimate
- CNY 565.0M
Latest reported
- Last report date
- Oct 23, 2026
- EPS actual
- CNY 0.24
- EPS estimate
- CNY 0.15
- Revenue actual
- CNY 526.8M
- Revenue estimate
- CNY 526.8M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +58.2%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 23, 2026 | CNY 0.15 | CNY 0.24 | Beat 58.21% | CNY 526.8M |
| Aug 20, 2026 | — | CNY 0.22 | — | CNY 425.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 31, 2027